Tim B. F. Woodfield BE Mech, MASc, PhD

Professor Woodfield leads the Christchurch Regenerative Medicine and Tissue Engineering (CReaTE) Group which is associated with the University of Otago’s Department of Orthopaedic Surgery and its Centre for Bioengineering & Nanomedicine. The Department’s location at the Christchurch hospital campus helps him maintain strong connections with the city’s medical and surgical staff, and the Centre draws upon talent across several disciplines based out of the University’s Dunedin, Christchurch, and Wellington locations in New Zealand. His CReaTE Group is pursuing stem cell and biomaterial-based strategies for musculoskeletal tissue regeneration and is primarily investigating their application in the clinical translation of orthopaedic medical devices & cell-based therapies.

The Group’s research technology platform includes complex 3D Biofabrication and Additive Manufacturing of biomaterial scaffolds and titanium medical devices applied to regenerative medicine of cartilage and bone, including novel bio-ink/bio-resin development, delivery of novel biofilm inhibitors, advanced 3D tissue culture models, and high throughput screening. Tim is a Principal Investigator within the New Zealand Medical Technology Centre of Research Excellence (CoRE), and he is an adjunct Associate Professor in the Institute of Health & Biomedical Innovation, Queensland University of Technology, in Australia, as well as for the Auckland Bioengineering Institute, in the University of Auckland, New Zealand.

Tim is a previous recipient of a prestigious Rutherford Discovery Fellowship, awarded to him by the Royal Society of New Zealand. He serves the International Society for Biofabrication (ISBF) as its President-Elect and Executive Board Member and is the former President of the Australasian Society for Biomaterials & Tissue Engineering (ASBTE). He also sits on the Asia Pacific Council for the Tissue Engineering and Regenerative Medicine International Society (TERMIS) and is an Editorial Board Member for Biofabrication, APL Bioengineering, and Frontiers in Bioengineering & Biotechnology.